Skip to content

Clinical trials

Immune System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Country / region: Germany Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20102
20112
20122
20131
20142
20151
20164
20174
20185
20192
20213
20223
20237
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated12
Active, not recruiting7
Recruiting5
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Pfizer3
Celgene2
Cogent Biosciences, Inc.2
GlaxoSmithKline2
Jasper Therapeutics, Inc.2
Nordic Nanovector2
Novartis Pharmaceuticals2
UCB Pharma2
Viatris Innovation GmbH2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases46
Autoimmune Diseases21
Connective Tissue Diseases11
Lupus Erythematosus, Systemic9
Lymphoproliferative Disorders8
Hypersensitivity7
Lymphatic Diseases7
Skin Diseases7
Hematologic Diseases6
Lymphoma6

Trials

Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.